37 related articles for article (PubMed ID: 32345304)
1. NDRG2 acts as a negative regulator of the progression of small-cell lung cancer through the modulation of the PTEN-AKT-mTOR signalling cascade.
Ma Z; Ma Y; Feng J; Xu Z; Cheng C; Qin J; Li S; Jiang J; Kong R
Toxicol Appl Pharmacol; 2024 Apr; 485():116915. PubMed ID: 38537875
[TBL] [Abstract][Full Text] [Related]
2. Sulforaphane regulates apoptosis- and proliferation‑related signaling pathways and synergizes with cisplatin to suppress human ovarian cancer.
Kan SF; Wang J; Sun GX
Int J Mol Med; 2018 Nov; 42(5):2447-2458. PubMed ID: 30226534
[TBL] [Abstract][Full Text] [Related]
3. NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity.
Shen L; Liu X; Hou W; Yang G; Wu Y; Zhang R; Li X; Che H; Lu Z; Zhang Y; Liu X; Yao L
Cell Mol Life Sci; 2010 Apr; 67(8):1371-81. PubMed ID: 20127388
[TBL] [Abstract][Full Text] [Related]
4. Astrocyte-specific NDRG2 gene: functions in the brain and neurological diseases.
Li X; Wu X; Luo P; Xiong L
Cell Mol Life Sci; 2020 Jul; 77(13):2461-2472. PubMed ID: 31834421
[TBL] [Abstract][Full Text] [Related]
5. A benzimidazolium salt induces apoptosis and arrests cells at sub-G1 phase in epithelial ovarian cancer cells.
Akar S; Cakir M; Ozkol H; Akkoc S; Ozdem B
Mol Biol Rep; 2024 Jan; 51(1):66. PubMed ID: 38170294
[TBL] [Abstract][Full Text] [Related]
6. Anticancer Effects of BRD4 Inhibitor in Epithelial Ovarian Cancer.
Kim Y; Park WH; Suh DH; Kim K; No JH; Kim YB
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473320
[TBL] [Abstract][Full Text] [Related]
7. NDRGs in Breast Cancer: A Review and In Silico Analysis.
Villodre ES; Nguyen APN; Debeb BG
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611020
[TBL] [Abstract][Full Text] [Related]
8. NDRG2 Promotes Lens Epithelial Cells Senescence via NLRP3/Caspase1-Mediated Pyroptosis.
Zhang H
Appl Biochem Biotechnol; 2023 Dec; ():. PubMed ID: 38158484
[TBL] [Abstract][Full Text] [Related]
9. Targeted Overexpression of NDRG2 using Survivin Promoter Reduces Viability and Invasiveness of A549 Cell Line.
Fanian M; Rafiei G; Alizadeh Zarei M; Takhshid MA
Avicenna J Med Biotechnol; 2023; 15(2):84-90. PubMed ID: 37034887
[TBL] [Abstract][Full Text] [Related]
10. The Crosstalk Between Signaling Pathways and Cancer Metabolism in Colorectal Cancer.
Hon KW; Zainal Abidin SA; Othman I; Naidu R
Front Pharmacol; 2021; 12():768861. PubMed ID: 34887764
[TBL] [Abstract][Full Text] [Related]
11. Integrated multi-omics analysis of ovarian cancer using variational autoencoders.
Hira MT; Razzaque MA; Angione C; Scrivens J; Sawan S; Sarker M
Sci Rep; 2021 Mar; 11(1):6265. PubMed ID: 33737557
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of NDRG2 promotes the therapeutic effect of pazopanib on ovarian cancer.
Cui Y; Shen G; Ma L; Lv Q
J Recept Signal Transduct Res; 2021 Dec; 41(6):546-552. PubMed ID: 33050824
[TBL] [Abstract][Full Text] [Related]
13. Downregulated expression levels of USP46 promote the resistance of ovarian cancer to cisplatin and are regulated by PUM2.
Xu L; Zhang B; Li W
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576437
[TBL] [Abstract][Full Text] [Related]
14. Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancer.
Hu W; Fan C; Jiang P; Ma Z; Yan X; Di S; Jiang S; Li T; Cheng Y; Yang Y
Oncotarget; 2016 Jan; 7(1):209-23. PubMed ID: 26506239
[TBL] [Abstract][Full Text] [Related]
15. N-myc Downstream-Regulated Gene 2 (NDRG2) Function as a Positive Regulator of Apoptosis: A New Insight into NDRG2 as a Tumor Suppressor.
Kim G; Lim S; Kim KD
Cells; 2021 Oct; 10(10):. PubMed ID: 34685629
[TBL] [Abstract][Full Text] [Related]
16. NDRG2 gene expression pattern in ovarian cancer and its specific roles in inhibiting cancer cell proliferation and suppressing cancer cell apoptosis.
Kang F; Wang Y; Luo Y; Zhang Y
J Ovarian Res; 2020 Apr; 13(1):48. PubMed ID: 32345304
[TBL] [Abstract][Full Text] [Related]
17. Propofol inhibits proliferation and cisplatin resistance in ovarian cancer cells through regulating the microRNA‑374a/forkhead box O1 signaling axis.
Sun Y; Peng YB; Ye LL; Ma LX; Zou MY; Cheng ZG
Mol Med Rep; 2020 Mar; 21(3):1471-1480. PubMed ID: 32016462
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
